AchieveRx Quit Co (ACHV): Next-Year EPS Estimate 53.58%
As of 2026-11-10, AchieveRx Quit Co (ACHV) has a next-year EPS growth estimate of 53.58%. Featured in our EPS revision report on 2026-08-19.
On 2026-10-21, analyst consensus for ACHV's next-year EPS growth shifted from 53.60% to 53.58% — a negative change of 0.02 percentage points. The revised estimate has been sustained across 17 subsequent trading sessions. Current-year growth is projected at -16.80%.
What's Driving This
ACHV has been rising primarily after analysts raised its next-year EPS growth estimate from 43.50% to 49.79% on 2026-08-13
Generated 2026-10-15 from news as of 2026-10-15
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 53.58%
- EPS growth this year
- -16.80%
- EPS next quarter (est)
- -$0.20
- Last price
- $6.78
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-11-10 | 53.58% | -16.80% | -$0.20 | $6.78 |
| 2026-11-09 | 53.58% | -16.80% | -$0.20 | $6.78 |
| 2026-11-07 | 53.58% | -16.80% | -$0.20 | $6.72 |
| 2026-11-06 | 53.58% | -16.80% | -$0.20 | $6.72 |
| 2026-11-05 | 53.58% | -16.80% | -$0.20 | $6.38 |
| 2026-11-04 | 53.58% | -16.80% | -$0.20 | $6.98 |
| 2026-11-03 | 53.58% | -16.80% | -$0.20 | $6.73 |
| 2026-11-02 | 53.58% | -16.80% | -$0.20 | $6.61 |
| 2026-10-31 | 53.58% | -16.80% | -$0.20 | $6.83 |
| 2026-10-30 | 53.58% | -16.80% | -$0.20 | $6.83 |
| 2026-10-29 | 53.58% | -16.80% | -$0.20 | $7.19 |
| 2026-10-28 | 53.58% | -16.80% | -$0.20 | $6.85 |
| 2026-10-27 | 53.58% | -16.80% | -$0.20 | $6.93 |
| 2026-10-26 | 53.58% | -16.80% | -$0.20 | $6.54 |
| 2026-10-23 | 53.58% | -16.80% | -$0.20 | $6.49 |
| 2026-10-22 | 53.58% | -16.80% | -$0.20 | $6.50 |
| 2026-10-21 | 53.58% | -16.80% | -$0.20 | $6.51 |
| 2026-10-20 | 53.60% | -16.80% | -$0.20 | $6.51 |
| 2026-10-19 | 53.60% | -16.80% | -$0.20 | $6.61 |
| 2026-10-16 | 53.60% | -16.80% | -$0.20 | $6.38 |
| 2026-10-15 | 53.60% | -16.80% | -$0.20 | $6.97 |
| 2026-10-14 | 53.60% | -16.80% | -$0.20 | $7.00 |
| 2026-10-13 | 53.60% | -16.80% | -$0.20 | $7.00 |
| 2026-10-12 | 53.60% | -16.80% | -$0.20 | $7.06 |
| 2026-10-11 | 53.60% | -16.80% | -$0.20 | $7.41 |
| 2026-10-10 | 53.60% | -16.80% | -$0.20 | $7.41 |
| 2026-10-09 | 53.60% | -16.80% | -$0.20 | $7.41 |
| 2026-10-08 | 53.60% | -16.80% | -$0.20 | $7.19 |
| 2026-10-07 | 53.60% | -16.80% | -$0.20 | $7.24 |
| 2026-10-06 | 53.60% | -16.80% | -$0.20 | $7.03 |
Reports Featuring ACHV
Recent News
- Achieve Life Sciences Reports Second Quarter 2026 Financial Results and Provides Business UpdatesGlobeNewswire
- Achieve Life Sciences Inc (ACHV) Q1 2026 Earnings Call Highlights: Strategic Financing and ...GuruFocus.com
- Achieve Life Sciences Strengthens Board and Commercial Leadership with Three Senior Appointments from Team Previously at Verona PharmaGlobeNewswire
- Achieve Life Sciences Reports First Quarter 2026 Financial Results and Provides Business UpdatesGlobeNewswire
- Achieve Life Sciences Inc (ACHV) Q4 2025 Earnings Call Highlights: Strategic Advances and ...GuruFocus.com
- Achieve Life Sciences Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their LossesNewsfile
- Achieve Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business UpdatesGlobeNewswire
Screen Performance
Aggregate stats across all 2145 tickers our top-EPS-revision screen has flagged over the past 225 days.
- Median return since detection
- -2.9%
- % of tickers in the green
- 43%
- Median return on winners
- +22.8%
- Large revisions captured
- 2246
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Also Tracked by Our Screen
Frequently Asked Questions
What is AchieveRx Quit Co's next-year EPS growth estimate?▾
As of 2026-11-10, AchieveRx Quit Co (ACHV) has a next-year EPS growth estimate of 53.58%, based on analyst consensus.
When was the latest EPS estimate revision for ACHV?▾
The most recent revision occurred on 2026-10-21, when analysts adjusted the next-year EPS growth estimate from 53.60% to 53.58%.
What sector and industry does AchieveRx Quit Co belong to?▾
AchieveRx Quit Co operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. ACHV appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. AchieveRx Quit Co (ACHV) appears here because it was detected by our daily top-EPS-revision-performer screen.